[
  {
    "ts": null,
    "headline": "Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain?",
    "summary": "TECH's Asuragen brand unveils a highly sensitive ESR1 mutation monitoring assay.",
    "url": "https://finnhub.io/api/news?id=b0cf66bb0769d1f8fcca51ece22b1b7eda04c3ee9eb23c95de08ee01692af69a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734005460,
      "headline": "Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain?",
      "id": 131930901,
      "image": "https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "TECH's Asuragen brand unveils a highly sensitive ESR1 mutation monitoring assay.",
      "url": "https://finnhub.io/api/news?id=b0cf66bb0769d1f8fcca51ece22b1b7eda04c3ee9eb23c95de08ee01692af69a"
    }
  },
  {
    "ts": null,
    "headline": "BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY",
    "summary": "Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities today announced a partnership with MedSanTek. Under the agreement, MedSanTek becomes the distributor of Bio-Techne's R&D Systems, Novus, Tocris, Protein Simple, Advanced Cell Diagnostics (ACD), and Asuragen brands across Turkey.",
    "url": "https://finnhub.io/api/news?id=9216842c6565e8882072a09e46015dba881afd919c2f57117cf76d9dd309c3eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734004800,
      "headline": "BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY",
      "id": 131930902,
      "image": "https://media.zenfs.com/en/prnewswire.com/f5bd457eba951c97e17e98b5c3c3878c",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities today announced a partnership with MedSanTek. Under the agreement, MedSanTek becomes the distributor of Bio-Techne's R&D Systems, Novus, Tocris, Protein Simple, Advanced Cell Diagnostics (ACD), and Asuragen brands across Turkey.",
      "url": "https://finnhub.io/api/news?id=9216842c6565e8882072a09e46015dba881afd919c2f57117cf76d9dd309c3eb"
    }
  }
]